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Abstract
Background: Early medical complications are potentially modifiable factors influencing in-hospital outcome. We
investigated the influence of acute complications on mortality and poor outcome 3 months after ischemic stroke.
Methods: Data were obtained from patients admitted to one of 13 stroke units of the Berlin Stroke Registry (BSR)
who participated in a 3-months-follow up between June 2010 and September 2012. We examined the influence of
the cumulative number of early in-hospital complications on mortality and poor outcome (death, disability or
institutionalization) 3 months after stroke using multivariable logistic regression analyses and calculated attributable
fractions to determine the impact of early complications on mortality and poor outcome.
Results: A total of 2349 ischemic stroke patients alive at discharge from acute care were included in the analysis.
Older age, stroke severity, pre-stroke dependency and early complications were independent predictors of mortality 3
months after stroke. Poor outcome was independently associated with older age, stroke severity, pre-stroke
dependency, previous stroke and early complications. More than 60% of deaths and poor outcomes were attributed
to age, pre-stroke dependency and stroke severity and in-hospital complications contributed to 12.3% of deaths and
9.1% of poor outcomes 3 months after stroke.
Conclusion: The majority of deaths and poor outcomes after stroke were attributed to non-modifiable factors.
However, early in-hospital complications significantly affect outcome in patients who survived the acute phase after
stroke, underlining the need to improve prevention and treatment of complications in hospital.
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Background
Despite achievements in early treatment, management and
secondary prevention, a substantial proportion of stroke
patients still experience severe consequences in terms of
mortality and morbidity [1-8]. A recent comparison of variations
in stroke consequences in different European regions reported
that 40% of first-ever stroke patients suffer from poor outcome
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in terms of impairment, institutionalization or death 3 months
after the index event [9]. Older age, stroke severity, comorbidity
and pre-stroke dependency have consistently been reported as
determinants for mortality and bad outcome after stroke
[7,9-12]. Early complications like pneumonia and increased
intracranial pressure have been shown to be independently
associated with increased mortality and poor functional
outcome [4,13-21]. We recently demonstrated that in-hospital
complications account for up to 13-29% of in-hospital morbidity
or mortality [4]. However, currently there is little evidence on
the longer-term effects of early complications on stroke
outcome. We aimed to examine the impact of early medical
complications on mortality and poor outcome 3 months after
ischemic stroke in patients discharged alive from acute care
hospital.
Methods
The Berlin Stroke Register
The Berlin Stroke Register (BSR) is a network of stroke units
in the city of Berlin (14 stroke units in June 2010) aiming to
improve acute treatment of stroke patients [22]. The hospitals
prospectively collect data for all patients with stroke or TIA in
order to continuously monitor quality of stroke care. The
participating stroke units currently document the treatment of
about 9 000 patients a year, thereby covering an estimated
80% of stroke patients in Berlin. Data collected by members of
the hospital staff include information on age, sex, stroke
severity, functional impairment at stroke onset, diagnostic and
therapeutic measures, early rehabilitation and secondary
prevention, and early complications. Data are collected in a
standardized way in all hospitals involved in the register.
Procedures and definitions of the items were set down in a
manual. 13 hospitals of the BSR participated in a separate
follow-up study of patients 3 months after stroke. Details on
methods and conduct of the follow-up have been published
previously [23]. Briefly, patient recruitment took part between
June 2010 and September 2011. Study participants received a
postal questionnaire 3 months after stroke or were offered to
answer the questions on the phone. If participants were unable
to answer the questionnaire or unable to be interviewed due to
cognitive impairment or communication difficulties, the
questions could also be answered by proxies. Data collected in
the follow-up included information about recurrent events, living
situation, utilization of rehabilitation services, current
medication as well as socioeconomic variables like formal
education and immigration background and functional
impairment. Impairment was assessed using the Barthel index.
Reliability of the postal version of the BI and the telephone
version with either patients or carers 3 months after stroke has
been demonstrated to be good to excellent when compared to
face-to-face interviews [24].
Study population
Patients who were admitted to one of the participating
hospitals after first or recurrent acute stroke or TIA within 7
days after onset of symptoms and aged ≥18 years were
included in the register. Patients who were alive at discharge
from hospital who gave informed consent to participate in the
study were followed up 3 months after stroke. The following
analyses were restricted to patients with ischemic stroke as
main diagnosis at discharge. Patients with TIA, intracerebral or
subarachnoid haemorrhage were excluded.
Definition of variables
Baseline characteristics.  During stay in hospital data were
collected on the following clinical characteristics: Severity of
neurological deficit according to the German version of the
National Institutes of Health Stroke Scale (NIHSS)[25],
functional impairment at stroke onset using the Barthel Index
[24], comorbidities (diabetes mellitus [elevated blood glucose
level or history of diabetes or medical treatment], atrial
fibrillation [documented by standard-ECG or long-term-ECG or
history of atrial fibrillation or medical treatment], previous stroke
[evidence for previous stroke lasting >24 hours in patient
record or imaging], hypertension [systolic blood pressure of
>140 mm Hg or diastolic blood pressure of >90 mm Hg or
medical treatment] and hypercholesterolemia [elevated
cholesterol level (>190 mg/dL) or history of
hypercholesterolemia or medical treatment]. Age and sex of the
patients as well as pre-stroke dependency, defined as
independent at home, nursing care at home or living in a
nursing home) were also documented by members of hospital
staff.
Early complications.  We acquired information on the
occurrence of early in-hospital complications, namely on
pneumonia [clinical or diagnostic findings of hospital-acquired
pulmonary infection], increased intracranial pressure [imaging
evidence of cerebral oedema or brain shift syndrome with
clinical deterioration]. Complications like urinary tract infection,
intracerebral bleeding, recurrent stroke, epileptic seizures,
thrombosis or pulmonary embolism and others were rated as
complications if they required diagnostic or therapeutic
measures. Within the current analysis, the cumulative number
of in-hospital complications was used to examine their
influence on patient outcome.
Mortality and poor outcome 3 months after stroke.  Poor
outcome 3 months after stroke was defined as death,
institutionalization due to stroke or dependency (defined as
Barthel Index < 60 points) based on previously published
recommendations.[26] Mortality was assessed using
information from the registration office which keeps records of
the vital status and date of death of all registered inhabitants.
Functional impairment was defined by the Barthel Index.[25]
The instrument assesses limitations in activities of daily living
(ADL) on a score from 0 (completely dependent) to 100
(independent). Institutionalization was defined as the new
requirement for nursing home care if patients had previously
been living in their own home.
Statistical analysis
Descriptive statistics were used to provide information on the
patients’ baseline characteristics and to assess mortality and
poor outcome 3 months after stroke.
Univariate logistic regression analyses were performed to
estimate the effect of early complications and of clinical or
Complications and Outcome 3 Months after Stroke
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demographic factors on 3-months mortality and poor outcome.
To estimate odds ratios (OR) and resulting 95% confidence
intervals (CI) of poor outcome or mortality three months after
stroke, we performed multivariable logistic regression analyses
including the number of early complications, age, sex, pre-
stroke dependency, comorbidities and stroke severity as
independent variables. Variables were eliminated using
backward selection methods. We calculated attributable
fractions (AFs) to examine the relevance of the factors included
in the model in terms of mortality and poor outcome after
stroke. Attributable fractions are defined as the proportional
reduction of an outcome if the exposure to a risk factor was
reduced to zero. They consider not only the association
between exposure and disease, but also the frequency of the
exposure in the population and thus help to estimate the risk
factor’s relevance on the population level. The method of
average sequential attributable fractions applied allows
obtaining estimates for several risk factors which do not add up
to more than 100% directly from logistic regression analyses
and the attributable fractions are independent from the order in
which they are inserted.[4,27] AFs were calculated for all
variables included in the final logistic regression model. The
independent variables were dichotomized before being
included in the model.
To examine whether the estimates found in the study might
be modified by selection bias we compared the baseline
characteristics of patients who participated in the follow-up with
those of the total population documented in the Berlin Stroke
Register (BSR). We used the chi-squared test for categorical
data to analyse whether age, stroke severity and functional
impairment at stroke onset were evenly distributed across
these groups. All tests were two-sided, and statistical
significance was determined at an alpha level of 0.05.
Statistical analyses were performed with the SPSS Statistics
18.0 and SAS 9.2 software package.
Ethics approval
Patients or their legal representatives provided written
informed consent to participate in the study. The study has
been approved by the ethics committee of Charité –
Universitätsmedizin Berlin (EA1/061/10). The data
management was approved by the corresponding data
protection officer of the participating institutions.
Results
Between June 2010 and September 2011, 3222 patients
alive at discharge gave informed consent to participate in the
follow-up study, giving a participation rate of 64.9% of all
patients screened in the participating hospitals during the study
period [Figure 1]. Of all patients alive at discharge who agreed
to participate in the follow-up, information on survival 3 months
after stroke was available for a total of 3123 patients (96.9%).
We excluded patients with a final diagnosis of TIA (677
patients) or ICH (97 patients) leaving 2349 patients who were
included in the analyses on 3-months case fatality. Mortality of
patients with ischemic stroke between discharge from hospital
and 3 months after stroke was 3.5% (83 patients). 395 patients
(16.8%) could not be included in the analyses on poor outcome
3 months after stroke because of missing information on
functional impairment or current living situation. Therefore,
1954 patients with complete follow-up were included in further
analyses. Of those, 235 patients (12%) had a poor outcome in
terms of death, institutionalization or BI<60.
Baseline characteristics of the 2349 patients with information
on survival are presented in Table 1. Of the patients, 60% were
<75 years of age and 43.2% were females. Median NIHSS
score on admission of the patients was 3 (interquartile range 2
to 6). Functional impairment at stroke onset was severe or
moderate (BI 0-95) in 59% of the patients. Early medical
complications during stay in hospital occurred in 285 patients
(12.1%), in 47 patients (2.0%) at least two complications were
documented. The most common complications were urinary
tract infection (3.6%), pneumonia (2.3%) and recurrent strokes
(1.0%).
We examined differences in relevant determinants of
mortality and poor outcome between our study sample and the
total population of ischemic stroke patients documented in the
Berlin Stroke Register (BSR) alive at discharge between
06/2010 and 09/2011. Patients who participated in the follow-
up were significantly younger, less frequently dependent before
stroke, had less severe strokes and minor functional
impairment at stroke onset and less complications documented
during stay in hospital [data not shown].
Univariate analyses
Unadjusted analyses showed that the cumulative number of
complications was associated with higher case-fatality, which
also holds true for pneumonia and urinary tract infection, but
not for recurrent strokes, when included as distinct variables
[see Table 2]. Patients alive 3 months after stroke were also
significantly younger and much more likely to have had a
milder stroke than patients who had died. Case-fatality was
significantly higher among patients dependent on nursing care
(at home or in an institution) before stroke. Diabetes and atrial
fibrillation were also associated with higher mortality; sex,
however, did not have a significant effect on case-fatality.
The number of complications had a strong influence on poor
outcome at 3 months in univariate analyses. Included as
distinct variables, pneumonia, urinary tract infection and
recurrent strokes all showed a statistically significant
association with poor outcome. Higher odds for poor outcome
were also observed for older age, female sex, stroke severity
and pre-stroke dependency and for diabetes, atrial fibrillation,
hypertension and previous strokes.
Multivariable analyses
In multivariable analyses [Table 3], the number of
complications, older age, stroke severity and pre-stroke
dependency remained independent predictors of mortality 3
months after stroke.
In-hospital complications, older age, stroke severity, pre-
stroke dependency and previous strokes were found to be
predictors of poor outcome at 3 months.
Patients with documented complications during acute
treatment had more than two-fold increased odds of death (OR
Complications and Outcome 3 Months after Stroke
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2.48; 95% CI 1.44-4.28) or poor outcome (OR 2.50; 95% CI
1.65-3.79) 3 months after stroke. Case fatality of patients with
two or more complications was even higher (OR 4.45; 95% CI
1.86-10.64) as were the odds of poor outcome (OR 4.92; 95%
CI 2.19-11.05).
In a separate sensitivity analysis including infections
(pneumonia and urinary tract infections) and recurrent strokes
as distinct complications we found a significant effect on 3
months mortality for infections (OR 1.93; 95% CI 1.03-3.63),
but not for recurrent strokes. Having experienced an infection
(OR 3.03; 95% CI 1.78-5.17) or recurrent stroke (OR 12.21;
95% CI 3.83-38.96) had a substantial impact on poor outcome
at 3 months.
Attributable fractions
Attributable fractions for death and poor outcome 3 months
after stroke can be seen in Table 4. More than 60% of deaths
after discharge from hospital were attributed to age (31.4%),
pre-stroke dependency (11.0%) and stroke severity (22.3%).
Attributable risks of these factors on poor outcome at 3 months
were similar (overall 63.5%) with age having a smaller (21%)
and stroke severity a larger effect (27.5%). The proportion of
patients with poor outcome attributable to pre-stroke
dependency was slightly higher than the proportion of death
attributable to this factor (15% vs. 11%).
In-hospital complications contributed to 12.3% of deaths
during follow-up, the impact of complications on poor outcome
was slightly smaller (9.1%). An additional proportion of 7.7% of
poor outcomes could be attributed to previous strokes.
Discussion
In this study we analysed the independent influence of early
in-hospital complications on mortality and dependency 3
months after stroke in ischemic stroke patients alive at
discharge from hospital. We demonstrated that the occurrence
of early complications has a substantial impact on patient
outcome not only in the acute phase after stroke, but also in
the 3 months after the event. We noticed a cumulative effect
with patients suffering from more than one complication
showing significantly higher rates of both case-fatality and poor
outcome than patients with only one complication. At 12.3%
and 9.1% respectively, a considerable proportion of death and
poor outcome in the period after hospital discharge could be
attributed to in-hospital complications. A strong influence of
complications on early stroke outcome during hospitalisation
has previously been reported. A prior analysis from the Berlin
Stroke Register demonstrated that odds for in-hospital death
were more than 5 times increased for patients with pneumonia,
more than 30 times increased for patients with increased
Figure 1.  Flow chart of the study population.  
doi: 10.1371/journal.pone.0075719.g001
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intracranial pressure and more than 6 times increased for
patients with other in-hospital complications [4]. Consistent with
previous studies we found that older age, severity of
neurological deficit at stroke onset and pre-stroke dependency
are independent predictors of mortality and poor outcome
[1,13,28]. In contrast to the results of previous studies [1,13,17]
the presence of comorbidities other than previous strokes did
not have an independent influence on outcome in our study
sample.
Prior studies on the influence of early complications on
patient outcome mainly focus on the acute stroke phase,
however, little is known about their impact on longer-term
stroke outcome. Only few studies analyzed the influence of
early complications on outcome 3 months after ischemic stroke
[19-21,29].
Table 1. Baseline characteristics of the study population (n
= 2349).
Age group, y, n (%)  
<65 704 (30.0)
65-74 702 (29.9)
75-84 664 (28.3)
≥85 279 (11.9)
Female sex, n (%) 1015 (43.2)
Pre-stroke disability  
Home independent 2034 (86.6)
Nursing care at home 197 (8.4)
Nursing care in institution 94 (4.0)
NIHSS categories, n (%)  
<5 1485 (63.2)
5-15 750 (31.9)
>16 111 (4.7)
BI at stroke onset, n (%)  
Poor/moderate (0-95) 1363 (58.8)
Good (100) 955 (40.7)
Comorbidities  
Diabetes 674 (28.7)
Atrial fibrillation 552 (23.5)
Previous stroke 541 (23.0)
Hypertension 1937 (82.5)
Hypercholesterolemia 1401 (59.6)
Complications  
Pneumonia 53 (2.3)
Re-infarct 23 (1.0)
Urinary tract infection 84 (3.6)
Increased intracranial pressure 5 (0.2)
Intracerebral bleeding 16 (0.7)
Epileptic seizures 20 (0.9)
Thrombosis / pulmonary embolism 10 (0.4)
Other complications 126 (5.4)
Number of complications  
0 2064 (87.9)
1 238 (10.1)
≥2 47 (2.0)
doi: 10.1371/journal.pone.0075719.t001
Table 2. Univariate analyses: Mortality and poor outcome 3
months after stroke.
 
Mortality
n=2349   
Poor
outcome
n=1954   
 % Dead OR 95% CI % pooroutcome OR 95% CI
Total 3.5   12.0   
Age group, y       
<65 0.9 1.00  4.4 1.00  
65-74 1.9 2.20 0.83-5.81 7.8 1.84 1.11-3.03
75-84 5.3 6.47 2.71-15.49 16.7 4.38 2.77-6.92
≥85 10.4 13.50 5.54-32.89 31.8 10.16 6.21-16.63
Sex       
Male 2.9 1.00  9.7 1.00  
Female 4.3 1.51 0.97-2.33 15.2 1.67 1.27-2.20
Pre-stroke
disability       
Home
independent 2.4 1.00  8.1 1.00  
Nursing care at
home 9.6 4.32 2.49-7.51 37.3 6.74 4.60-9.87
Nursing care in
institution 16.0 7.69 4.14-14.31 60.3 17.18 10.26-28.77
NIHSS
categories       
<5 1.7 1.00  5.5 1.00  
5-15 5.7 3.55 2.15-5.86 22.8 5.09 3.74-6.93
16-25 14.2 9.63 4.91-18.89 38.0 10.53 6.30-17.60
>25 0 - - 50.0 17.20 2.39-123.9
Comorbidities
(n/y)       
Diabetes       
no 2.8 1.00  10.1 1.00  
yes 5.3 1.94 1.25-3.03 17.1 1.84 1.39-2.44
Atrial fibrillation       
no 2.6 1.00  9.3 1.00  
yes 6.5 2.59 1.66-4.04 20.9 2.56 1.93-3.40
Previous stroke       
no 3.2 1.00  9.6 1.00  
yes 4.8 1.54 0.96-2.48 20.7 2.48 1.86-3.30
Hypertension       
no 2.0 1.00  7.6 1.00  
yes 3.9 2.02 0.97-4.22 13.0 1.81 1.18-2.76
Hypercholes-
terolemia       
no 3.5 1.00  12.6 1.00  
yes 3.5 0.99 0.63-1.56 11.7 0.92 0.70-1.22
No. of
complications       
0 2.4 1.00  9.2 1.00  
1 10.1 4.52 2.72-7.50 31.0 4.42 3.10-6.29
≥2 19.1 9.54 4.38-20.79 52.9 10.55 5.54-22.26
Pneumonia  5.27 2.40-11.56  4.76 2.51-9.01
Re-infarcts  2.64 0.61-11.45  6.70 2.56-17.53
Complications and Outcome 3 Months after Stroke
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They demonstrated a similar increase in risk of poor outcome
and death in patients who experienced early complications like
urinary tract infections and pneumonia as we discovered in our
data, with patients experiencing multiple complications carrying
a higher risk of death than patients with only one complication
[20]. Another study reported an increased 1-year mortality rate
for patients experiencing early complications after stroke,
particularly pneumonia [14].
In our study, we found that early complications account for
an additional 12.3% of deaths occurring between discharge
and 3 months after stroke and for an additional 9.1% of poor
outcomes at 3 months. This result is in line with prior analyses
Table 2 (continued).
 
Mortality
n=2349   
Poor
outcome
n=1954   
Urinary tract
infections  5.74 3.04-10.86  10.30 5.96-17.76
doi: 10.1371/journal.pone.0075719.t002
Table 3. Multivariable analyses: Mortality and poor outcome
3 months after stroke.
 Mortality  
Poor
outcome   
 OR 95% CI P value OR 95% CI P value
Age group, y   <0.005   <0.005
<65 1.00   1.00   
65-74 1.89 0.71-5.06  1.47 0.86-2.51  
75-84 4.37 1.79-10.65  2.86 1.74-4.69  
≥85 6.76 2.66-17.20  4.40 2.52-7.69  
Pre-stroke
disability   0.016   <0.005
Home
independent 1.00   1.00   
Nursing care at
home 2.27 1.25-4.13  3.63 2.36-5.60  
Nursing care in
institution 2.43 1.19-4.95  6.79 3.72-12.39  
NIHSS
categories   <0.005   <0.005
<5 1.00   1.00   
5-15 2.22 1.31-3.77  3.41 2.43-4.79  
16-25 4.83 2.27-10.28  6.55 3.54-12.12  
>25 0.0 -  4.38 0.28-68.70  
Diabetes 1.60 0.99-2.59 0.056 1.39 0.99-1.94 0.057
Previous strokes    1.99 1.41-2.80 <0.001
No. of
complications   <0.001   <0.005
0 1.00   1.00   
1 2.48 1.44-4.28  2.50 1.65-3.79  
≥2 4.45 1.86-10.64  4.92 2.19-11.05  
doi: 10.1371/journal.pone.0075719.t003
of the BSR, which demonstrated that early complications (in
particular pneumonia, iICP, and others) accounted for 33% and
29% of in-hospital mortality in patients with lengths of stay
(LOS) in hospital ≤7 days and >7 days, respectively.
Complications also accounted for 15% of poor outcomes
(patients with LOS ≤7 days) and 13% of poor outcomes
(patients with LOS >7 days) at discharge from hospital [4]. Our
results thus confirm the assumption that, although their impact
on early outcome seems to be greatest, having experienced in-
hospital complications does not only affect short-term patient
outcome after stroke, but may also have serious consequences
several months after discharge from hospital.
We aimed to estimate the impact of early complications on
patient outcome since medical complications after stroke, as
opposed to other determinants of outcome, are potentially
modifiable, although not completely avoidable. Our results,
together with previous literature, underline the need to improve
prevention, early detection and treatment of medical
complications in stroke units. A prophylactic treatment to
prevent complications before they might occur has been
suggested as a potential third pillar to improve stroke outcome
besides acute treatment and secondary prevention [16]. The
implementation of evidence-based management protocols for
the treatment of complications in acute stroke units has
recently been shown to positively affect patient outcome. Early
mobilization of patients after ischemic stroke might also prove
helpful to reduce the risk of medical complications [30].
However, despite the fact that it might be possible to
significantly reduce the occurrence of early post-stroke
complications in hospital, deviations from evidence-based care
might also reflect patient and family preferences to withhold or
withdraw interventions that increase chances of survival. A
recent study estimated that up to 40% of inpatient stroke
mortality might be attributed to deliberate decisions against life-
sustaining measures [31].
Our study has strengths and limitations. The strengths of the
study are its large sample size and its multicentre approach.
The study’s limitations include a participation rate of 64.9%. In
20% of the participants we obtained information on survival
only. Information on function before hospitalization could be
estimated only roughly using the patients’ living situation before
stroke as a proxy. Having more detailed information on
patients’ pre-stroke status would be highly desirable. The
occurrence of in-hospital complications in our sample is lower
Table 4. Attributable risks of deaths and poor outcome 3
months after ischemic stroke.
 Mortality Poor outcome at 3 months
Age ≤ 75 y 31.4 21.0
Pre-stroke dependency 11.0 15.0
NIHSS score ≥ 5 22.3 27.5
Diabetes mellitus 6.5 4.0
Previous strokes NS 7.7
No. of complications ≥1 12.3 9.1
Total explained 83.5 84.3
doi: 10.1371/journal.pone.0075719.t004
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than complication rates reported in the previous study [4]. This
is mainly due to the fact that we included only patients who
were alive at discharge from hospital. Since early complications
are a major factor influencing in-hospital death our estimates
for incident complications are considerably decreased by not
including patients who died during stay in hospital. This
restriction also means our data allow conclusions only on the
effect of early complications on patients who survived the acute
phase after stroke, not on their overall impact on 3 months
outcome. A comparison of our study population to all registered
patients alive at discharge from hospital showed that patients in
our sample were significantly younger, had a better pre-stroke
condition and were less severely affected, thus suggesting the
presence of selection bias in our sample. This might further
help to explain the reduced incidence of complications in our
study population. However, even in a sample of less affected
stroke patients we could demonstrate a strong impact of in-
hospital complications on both mortality and poor outcome 3
months after stroke.
Conclusion
With the majority of deaths and poor outcomes in ischemic
stroke patients alive at hospital discharge being attributable to
non-modifiable risk factors like age and stroke severity, early
complications have been shown to significantly affect patient
outcome not only in the short term, but also several months
after acute treatment. Some of these complications might be
preventable or can be effectively treated if detected early. Early
diagnosis of complications as well as evidence-based
management is of major importance to reduce their potential
consequences. A stronger focus of further research activities
on these potentially modifiable determinants of stroke outcome
and on efforts to improve interventions to prevent and treat
post-stroke complications is therefore required.
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